These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31798214)

  • 41. Is microwave ablation more effective than radiofrequency ablation in achieving local control for primary pulmonary malignancy?
    Tsakok MT; Jones D; MacNeill A; Gleeson FV
    Interact Cardiovasc Thorac Surg; 2019 Aug; 29(2):283–286. PubMed ID: 30929016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer.
    Bibok A; Kim DW; Malafa M; Kis B
    World J Gastroenterol; 2021 Jul; 27(27):4322-4341. PubMed ID: 34366607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New technologies in tumor ablation.
    Singla N; Gahan J
    Curr Opin Urol; 2016 May; 26(3):248-53. PubMed ID: 26967263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiofrequency ablation and breast cancer: a review.
    Nguyen T; Hattery E; Khatri VP
    Gland Surg; 2014 May; 3(2):128-35. PubMed ID: 25083506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in patterns of care: reablation and nephrectomy rates after needle ablative therapy for renal masses stratified by medical specialty.
    Long L; Park S
    J Endourol; 2009 Mar; 23(3):421-6. PubMed ID: 19260799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound-guided ablative therapy for hepatic malignancies : a comparison of the therapeutic effects of microwave and radiofrequency ablation.
    Zhang XG; Zhang ZL; Hu SY; Wang YL
    Acta Chir Belg; 2014; 114(1):40-5. PubMed ID: 24720137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors.
    Ansari D; Andersson R
    World J Gastroenterol; 2012 Mar; 18(10):1003-8. PubMed ID: 22416173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
    Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
    Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
    Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cryoablation - back again?].
    Isfort P; Penzkofer T; Mahnken AH
    Radiologe; 2012 Jan; 52(1):29-37. PubMed ID: 22249699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimally invasive ablative techniques in the treatment of breast cancer: a systematic review and meta-analysis.
    Peek MCL; Ahmed M; Napoli A; Usiskin S; Baker R; Douek M
    Int J Hyperthermia; 2017 Mar; 33(2):191-202. PubMed ID: 27575566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
    Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
    Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
    Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation.
    Abbas G; Schuchert MJ; Pennathur A; Gilbert S; Luketich JD
    Thorac Surg Clin; 2007 May; 17(2):261-71. PubMed ID: 17626404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microwave ablation: How we do it?
    Gala KB; Shetty NS; Patel P; Kulkarni SS
    Indian J Radiol Imaging; 2020; 30(2):206-213. PubMed ID: 33100690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local ablative treatments for hepatocellular carcinoma: An updated review.
    Facciorusso A; Serviddio G; Muscatiello N
    World J Gastrointest Pharmacol Ther; 2016 Nov; 7(4):477-489. PubMed ID: 27867681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.
    Ito K; Soga S; Seguchi K; Shinchi Y; Masunaga A; Tasaki S; Kuroda K; Sato A; Asakuma J; Horiguchi A; Shinmoto H; Kaji T; Asano T
    Oncol Lett; 2017 Jul; 14(1):918-924. PubMed ID: 28693252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy.
    Joniau S; Tsivian M; Gontero P
    Minerva Urol Nefrol; 2011 Sep; 63(3):227-36. PubMed ID: 21993321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiofrequency ablation of renal tumors.
    Mahnken AH; Günther RW; Tacke J
    Eur Radiol; 2004 Aug; 14(8):1449-55. PubMed ID: 15150668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiofrequency ablation: a minimally invasive approach in kidney tumor management.
    Salagierski M; Salagierski MS
    Cancers (Basel); 2010 Nov; 2(4):1895-900. PubMed ID: 24281207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.